Lunai Bioworks Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LNAI | KALA | NIKI | CLDI | GRI | PCSA | |
|---|---|---|---|---|---|---|
| Market cap | 5.03M | 5.42M | 9.42M | 3.49M | 3.43M | 5.31M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | 0.0 | — | -1.1 | -0.8 | -0.5 |
| Price/book | -0.5 | 0.6 | 0.1 | 0.6 | 0.3 | -16.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −86.75% | −99.61% | −74.68% | −96.44% | −96.64% | −86.21% |
| Today | −9.76% | −4.76% | −24.50% | −7.78% | −9.77% | +25.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LNAI news ›Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe
Lunai Bioworks ( (LNAI) ) has issued an update. More about Lunai Bioworks Lunai Bioworks, Inc. is a biotechnology company whose common stock is listed on Nasdaq, giving it exposure to public equity markets and to trading practices…
Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling
TradingView Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling Lunai Bioworks requested Nasdaq immediately suspend trading in its common stock while alleged irregular trading is reviewed. - Submitted urgent…
[8-K] Lunai Bioworks Inc. Reports Material Event
Btab Defines Its Vision as a Generational Project for the AI Era Datavault AI to Attend the 2026 Maxim Growth Summit Lunai submitted a request to Nasdaq to immediately suspend trading in its common stock, but Nasdaq had made no decision as…
Lunai Bioworks (LNAI): Performance Hinges on Cash Runway and Platform Proof - Alphastreet
That makes the next earnings report less about a conventional earnings beat or miss and more about three investor questions: whether operating losses are narrowing, whether cash is sufficient to support the platform strategy, and whether…
Lunai Bioworks files second amended complaint against six broker-dealers in Delaware
Lunai Bioworks has filed a second amended complaint in the U.S. District Court for the District of Delaware. The legal action targets six registered broker-dealers and two broker-dealer principals as defendants. The case is being heard in…
Lunai Bioworks estimates $3.2M loss for FY2026
The preliminary net loss estimate reflects the absence of a prior-year goodwill impairment charge and other offsetting fiscal 2026 items. Lunai Bioworks Inc. (LNAI) said it cannot file its fiscal 2026 Form 10-K within the prescribed period…
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Exclusive worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's workflow, connecting patient-derived subtypes with disease mechanisms, biomarkers and therapeutic targets ...
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
WILMINGTON, Del. and SACRAMENTO, Calif., Sept. 4, 2026/ PRNewswire/-- Lunai Bioworks, Inc. today issued this correction to the press release the Company distributed on August 27, 2026 under the headline " Lunai Bioworks Names Six…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net2
-
morningstar.com1
-
news.alphastreet.com1
-
scanx.trade1
-
theglobeandmail.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.